NCT05657977

Brief Summary

Transient tachypnea of newborn (TTN) causes 42.5%-60% of non-infectious respiratory distress cases in newborns, it is seen in only 1% of all newborns. In the etiology of TTN, it results from the inability to effectively clear the fetal lung fluid immediately after birth. The most known risk factors of TTN are; prematurity, malpresentation, abnormal birth, premature rupture of the membrane, meconium aspiration, fetal distress, multiple pregnancy, male gender, and low Apgar score. TTN; It typically occurs in term and late preterm newborns within the first two hours of life. For the diagnosis of TTN, respiratory rate \>60/min in the first 6-12 hours shows signs of groaning and retraction and improve spontaneously within a few days with 40% or less supportive oxygen therapy. However, in some rare cases, prolongation of symptoms, noninvasive mechanical ventilation support \[nasal continuous positive airway pressure (nCPAP), nonsynchronized nasal intermittent mandatory ventilation (NIMV)\] and in some cases invasive (intubated) mechanical ventilation may be required. Reducing pain and stress in mechanically ventilated infants is important for the prevention of complications that may occur in the future-early period and for recover process. While providing standard health care in the Neonatal Intensive Care Unit (NICU), sources of pain and stress should be identified and controlled. It is necessary to minimize the interventions that will cause pain and stress and to ensure that the newborn copes with the pain. In order to relieve pain and stress, various pharmacological (opioid, non-opioid analgesics) and non-pharmacological (breast milk, pacifier, kangaroo care, flexion posture, swaddling etc.) within the framework of family-centered care and individualized developmental care methods should be used. Pain control is a priority in neonatal nursing care, and it is the nurses; responsibility to select and implement a non-pharmacological intervention to reduce the level of pain. A limited number of studies have been found examining the effects of therapeutic touch and mothers voice on pain and comfort level in newborns, as a behavioral intervention, on relieving stress of body positioning in premature newborns who underwent nCPAP. There was no study found that the swaddling method applied during the procedure in patients followed up on nCPAP had an effect on reducing the stress level of newborns.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 1, 2022

Completed
4 months until next milestone

First Posted

Study publicly available on registry

December 20, 2022

Completed
10 days until next milestone

Study Start

First participant enrolled

December 30, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2023

Completed
Last Updated

July 12, 2023

Status Verified

September 1, 2022

Enrollment Period

2 months

First QC Date

September 1, 2022

Last Update Submit

July 11, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • First inclusion criteria eligible 20 newborn will be add this study.

    The saliva-specific Enzyme-Linked ImmunoSorbent Assay (ELISA) will be used for the study, for determine research results (pretest, posttest)

    up to 2 months

Study Arms (2)

Pretest

NO INTERVENTION

Pretest: The newborn connected to nCPAP will be placed in the supine position and slight extension position on the neck of the newborn to ensure airway patency. The first saliva sample will be taken to measure cortisol level in the 30th minute after the first cry from the newborn who is connected to nasal CPAP. Immediately after the saliva sample is taken in pretest group, the stress level determined by using the "neonatal stress scale", vital signs (respiration, heart rate, oxygen saturation), saliva sample collection time will be recorded on the chart.

Posttest, swaddling

EXPERIMENTAL

Posttest: The swaddling method will be applied to the newborn after the first saliva sample is taken. A second saliva sample will be taken 30 minutes after swaddling to measure cortisol level. Immediately after the saliva sample is taken in posttest group, the stress level determined by using the "neonatal stress scale", vital signs, saliva sample collection time will be recorded on the chart.

Other: nonpharmacologic intervention (swaddling)

Interventions

Swaddling method;The newborn will be placed on a square fabric blanket in the flexion and abduction position and will be loosely swaddled with a blanket.

Posttest, swaddling

Eligibility Criteria

Age10 Minutes - 5 Hours
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Birth week greater than 35 and birth weight greater than 2000 g,
  • Need for nasal CPAP/noninvasive mechanical ventilator,
  • Legal guardians' consent to participate in the research,
  • Diagnosis of neonatal transient tachypnea after delivery.

You may not qualify if:

  • Mother:
  • Taking cortisol-containing medication during the antenatal period
  • Taking drugs during the antenatal period
  • Being chorioamnionitis
  • Metabolic disease (adrenal insufficiency, etc.)
  • Newborn:
  • Amniotic fluid stained with meconium
  • Intubation
  • Apgar score below 6
  • Taking analgesic and narcotic drugs for sedation
  • Newborn taking cortisol-containing medication
  • Inability to obtain a saliva sample or if it is contaminated with blood
  • Signs of nasal injury during noninvasive mechanical ventilation
  • Congenital defects that will prevent the wrapping method (spina bifida, gastroschisis, etc.)
  • Performing resuscitation
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kutahya Health Sciences University

Kütahya, Turkey (Türkiye)

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
Just one researcher has to blinded.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Model Details: The one-group, pretest, posttest research design.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 1, 2022

First Posted

December 20, 2022

Study Start

December 30, 2022

Primary Completion

February 28, 2023

Study Completion

June 1, 2023

Last Updated

July 12, 2023

Record last verified: 2022-09

Locations